VBI Vaccines, Inc. - stock earnings
VBIV Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -20.4 million USD | 6.6 million USD |
| 2023Q2 | -44.6 million USD | 720000 USD |
| 2023Q1 | -37.4 million USD | 485000 USD |
| 2022Q4 | -19.6 million USD | 293000 USD |
| 2022Q3 | -28.1 million USD | 317000 USD |
| 2022Q2 | -67.6 million USD | 346000 USD |
| 2022Q1 | -25.6 million USD | 126000 USD |
| 2021Q4 | -18.8 million USD | 81000 USD |
| 2021Q3 | -15.8 million USD | 107000 USD |
| 2021Q2 | -17.5 million USD | 142000 USD |
| 2021Q1 | -17.6 million USD | 301000 USD |
| 2020Q4 | -15.4 million USD | 164000 USD |
| 2020Q3 | -13.0 million USD | 298000 USD |
| 2020Q2 | -9.5 million USD | 184000 USD |
| 2020Q1 | -8.4 million USD | 415000 USD |
| 2019Q4 | -10.9 million USD | 574000 USD |
| 2019Q3 | -16.2 million USD | 647000 USD |
| 2019Q2 | -13.2 million USD | 640000 USD |
| 2019Q1 | -14.6 million USD | 360000 USD |
| 2018Q4 | -19.3 million USD | 2.7 million USD |
| 2018Q3 | -15.4 million USD | 259000 USD |
| 2018Q2 | -16.7 million USD | 234000 USD |
| 2018Q1 | -12.3 million USD | 178000 USD |
| 2017Q4 | -11.5 million USD | 201000 USD |
| 2017Q3 | -9.8 million USD | 193000 USD |
| 2017Q2 | -9.0 million USD | 344000 USD |
| 2017Q1 | -8.6 million USD | 127000 USD |
| 2016Q4 | -8.4 million USD | 137000 USD |
| 2016Q3 | -7.3 million USD | 281000 USD |
| 2016Q2 | -6.4 million USD | 82000 USD |
| 2016Q1 | -1.1 million USD | 48000 USD |
| 2015Q4 | -4.9 million USD | -10000 USD |
| 2015Q3 | -6.9 million USD | 104000 USD |
| 2015Q2 | -1.7 million USD | 438000 USD |
| 2015Q1 | -62.8 million USD | 423000 USD |
| 2014Q4 | -1.3 million USD | ? USD |
| 2014Q3 | -815418 USD | ? USD |
| 2014Q2 | -1.1 million USD | 4.4 million USD |
| 2014Q1 | -1.5 million USD | 498603 USD |
| 2013Q4 | -1.6 million USD | ? USD |
| 2013Q3 | -1.1 million USD | ? USD |
| 2013Q2 | -461374 USD | ? USD |
| 2013Q1 | -316985 USD | ? USD |
| 2012Q4 | -1.1 million USD | ? USD |
| 2012Q3 | -3.4 million USD | ? USD |
| 2012Q2 | -1.8 million USD | ? USD |
| 2012Q1 | -3.2 million USD | ? USD |
| 2011Q4 | -2.8 million USD | ? USD |
| 2011Q3 | -3.3 million USD | ? USD |
| 2011Q2 | -4.0 million USD | ? USD |
| 2011Q1 | -14.5 million USD | ? USD |
| 2010Q4 | -655374 USD | ? USD |
| 2010Q3 | -3.3 million USD | ? USD |
| 2010Q2 | -257719 USD | ? USD |
| 2010Q1 | -383943 USD | ? USD |
| 2009Q4 | -166313 USD | ? USD |
| 2009Q3 | -77045 USD | ? USD |
| 2009Q2 | -79438 USD | ? USD |
| 2009Q1 | -75216 USD | ? USD |
| 2008Q4 | -61262 USD | ? USD |
| 2008Q3 | -87559 USD | ? USD |
| 2008Q2 | -59012 USD | ? USD |
| 2008Q1 | -126068 USD | 16629 USD |
| 2007Q4 | -161184 USD | ? USD |
| 2007Q3 | -188848 USD | ? USD |
| 2007Q2 | -76114 USD | ? USD |
| 2007Q1 | 1367 USD | ? USD |
| 2006Q4 | -59544 USD | ? USD |
| 2006Q3 | -88700 USD | ? USD |
| 2006Q2 | -66033 USD | ? USD |
| 2006Q1 | -218353 USD | ? USD |
| 2005Q4 | -34764 USD | ? USD |
| 2005Q3 | -47903 USD | ? USD |
| 2005Q2 | -42339 USD | ? USD |
| 2005Q1 | 23332 USD | ? USD |
| 2004Q4 | -17448 USD | ? USD |
| 2004Q3 | -21191 USD | ? USD |
| 2004Q2 | -21157 USD | ? USD |
| 2004Q1 | -29018 USD | ? USD |
| 2003Q4 | -45979 USD | ? USD |
| 2003Q3 | -30016 USD | ? USD |
| 2003Q2 | -29352 USD | ? USD |
| 2003Q1 | -47525 USD | ? USD |
| 2002Q4 | -8816 USD | ? USD |
| 2002Q3 | -18989 USD | ? USD |
| 2002Q2 | -10679 USD | ? USD |
| 2002Q1 | -523405 USD | ? USD |
| 2001Q4 | -11530 USD | ? USD |
| 2001Q3 | -10586 USD | 282 USD |
| 2001Q2 | -18860 USD | 0 USD |
| 2001Q1 | -82249 USD | 0 USD |
| 2000Q4 | -21715 USD | 0 USD |
| 2000Q3 | -61756 USD | 0 USD |
| 2000Q2 | ? USD | 67515 USD |
| 2000Q1 | 200 USD | -200 USD |
| 1999Q4 | ? USD | 69045 USD |
| 1999Q3 | -68094 USD | 68094 USD |
| 1999Q2 | ? USD | 67834 USD |
| 1999Q1 | -133819 USD | 1280 USD |
| 1998Q4 | ? USD | 64989 USD |
| 1998Q3 | -65509 USD | 65509 USD |
| 1998Q2 | ? USD | 68068 USD |
| 1998Q1 | -282355 USD | 566 USD |
| 1997Q4 | ? USD | 69881 USD |
| 1997Q3 | ? USD | 72390 USD |
| 1997Q2 | ? USD | 72432 USD |
VBIV Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -114.0 million USD | 8.1 million USD |
| 2022 | -141.0 million USD | 1.1 million USD |
| 2021 | -72.7 million USD | 631000 USD |
| 2020 | -47.3 million USD | 1.1 million USD |
| 2019 | -55.8 million USD | 2.2 million USD |
| 2018 | -63.6 million USD | 3.4 million USD |
| 2017 | -39.0 million USD | 865000 USD |
| 2016 | -23.2 million USD | 548000 USD |
| 2015 | -14.8 million USD | 955000 USD |
| 2014 | -65.9 million USD | 2.9 million USD |
| 2013 | -6.7 million USD | -1.6 million USD |
| 2012 | -13.2 million USD | ? USD |
| 2011 | -18.9 million USD | ? USD |
| 2010 | -716982 USD | ? USD |
| 2009 | -716982 USD | ? USD |
| 2008 | -558396 USD | ? USD |
| 2007 | -205286 USD | ? USD |
| 2006 | -343483 USD | ? USD |
| 2005 | -137070 USD | 79 USD |
| 2004 | -51380 USD | ? USD |
| 2003 | -137070 USD | 79 USD |
| 2002 | -89907 USD | 493 USD |
| 2001 | -563353 USD | 508 USD |
| 2000 | -187673 USD | ? USD |
| 1999 | -68844 USD | 68844 USD |
| 1998 | -198809 USD | 66269 USD |
| 1997 | -352236 USD | 70447 USD |
| 1996 | -217407 USD | 72469 USD |
VBIV
Price: $0.57
52 week price:
Earnings Per Share: -9.79 USD
P/E Ratio: -0.07
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 314214
Ebitda: -32.9 millionMarket Capitalization: 16.8 million
Average Dividend Frequency: 1